# Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
## first: Denise M. Wolf, last: Laura J vant Veer
## Cancer Cell 2022

### Motivation

### Method

### Insight

### Contribution Summary
